Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
4.8
56.38%
40%
—
59.82%
60%
—
5 Years
Score4.8
Net Growth56.38%
Net Trend40%
Net Income Consistency—
Rev Growth59.82%
Rev Trend60%
Revenue Consistency—
Bionano Genomics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 8M to $ 28M and net income went from -$ 41M to -$ 26M. Revenue increased in 3 of those 5 years; net income in 2.
Bionano Genomics Inc currently holds a 5-year HDB Score of 4.8 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 1.20 | — |
1 Year2025-08-12 | $ 3.08 | -61.04% |
5 Years2021-08-12 | $ 3.58K | -99.97% |
All Time2018-08-21 | $ 3.69K | -99.97% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2018-08-21 |
|---|---|---|---|---|
| Price | $ 1.20 | $ 3.08 | $ 3.58K | $ 3.69K |
| Return | — | -61.04% | -99.97% | -99.97% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 28M | -$ 31M | $ 24M |
| 2025 | $ 28M | -$ 26M | $ 13M |
| 2024 | $ 30M | -$ 112M | $ 9M |
| 2023 | $ 36M | -$ 232M | $ 66M |
| 2022 | $ 27M | -$ 132M | $ 113M |
| 2021 | $ 17M | -$ 72M | $ 250M |
| 2020 | $ 8M | -$ 41M | $ 38M |
| 2019 | $ 10M | -$ 29M | $ 17M |
| IPO2018 | $ 12M | -$ 18M | $ 16M |
Explore beyond BNGO
You're looking at Bionano Genomics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
